jaw pain glp 1 medications like Ozempic, Wegovy, Mounjaro, and Zepbound were designed for diabetes and weight loss. But newer research is exploring something unexpected. Their potential effects on the nervous GLP-1 diabetes and weight-loss drug

GLP-1 agonists mimic the GLP-1 hormone, helping regulate insulin, glucose, and appetite

doi: Fras JP, Davies MJ, Rosenstock J, et al

doi:10.1111/jocd.15869

adults are overweight or obese, only four percent of these people are prescribed GLP-1 weight-loss medicines due to concerns about safety or effectiveness, lack of healthcare provider training in weight management, excessive costs due to insurance companies refusing coverage and a toxic stigma that portrays obesity as a lack of willpower

Many manufacturers offer savings programs

Cardiovascular benefits of GLP-1 The SELECT trial demonstrated that GLP-1 therapy rapidly reduces heart attacks and strokes. These cardiovascular benefits have long been hinted at in diabetes trials, but the magnitude observed in SELECT surprised even seasoned cardiologists